Literature DB >> 29767583

Toward health technology assessment of whole-genome sequencing diagnostic tests: challenges and solutions.

Katherine Payne1, Martin Eden1, Niall Davison1, Egbert Bakker2.   

Abstract

Whole-genome sequencing (WGS) is being applied within research settings across Europe to develop genomic WGS-based diagnostic tests. The focus of this perspective paper is to describe if, and how, current approaches of health technology assessment could be applied to WGS-based diagnostic tests. This perspective draws on the collective view from a trans-European multidisciplinary consortium of methodologists, clinicians and scientists. Specific challenges can be described by using the PICO (population, intervention, comparator, outcome) framework to inform health technology assessment. Practical solutions are suggested which require joined-up, multidisciplinary working across healthcare systems using existing expert networks so that emergent issues for the health technology assessment of WGS can be met in a timely fashion.

Keywords:  3Gb; cost–effectiveness analysis; diagnosis; economic evaluation; genomics; health technology assessment; next-generation sequencing; resource allocation; whole-genome sequencing

Mesh:

Year:  2017        PMID: 29767583     DOI: 10.2217/pme-2016-0089

Source DB:  PubMed          Journal:  Per Med        ISSN: 1741-0541            Impact factor:   2.512


  6 in total

Review 1.  Methodological Issues in Assessing the Economic Value of Next-Generation Sequencing Tests: Many Challenges and Not Enough Solutions.

Authors:  Kathryn A Phillips; Patricia A Deverka; Deborah A Marshall; Sarah Wordsworth; Dean A Regier; Kurt D Christensen; James Buchanan
Journal:  Value Health       Date:  2018-08-08       Impact factor: 5.725

2.  Estimating the costs of genomic sequencing in cancer control.

Authors:  Louisa G Gordon; Nicole M White; Thomas M Elliott; Katia Nones; Anthony G Beckhouse; Astrid J Rodriguez-Acevedo; Penelope M Webb; Xing J Lee; Nicholas Graves; Deborah J Schofield
Journal:  BMC Health Serv Res       Date:  2020-06-03       Impact factor: 2.655

Review 3.  Clinical utility of genomic sequencing: a measurement toolkit.

Authors:  Robin Z Hayeems; David Dimmock; David Bick; John W Belmont; Robert C Green; Brendan Lanpher; Vaidehi Jobanputra; Roberto Mendoza; Shashi Kulkarni; Megan E Grove; Stacie L Taylor; Euan Ashley
Journal:  NPJ Genom Med       Date:  2020-12-15       Impact factor: 8.617

4.  Assessing the cost-effectiveness of precision medicine: protocol for a systematic review and meta-analysis.

Authors:  Wenjia Chen; Thunyarat Anothaisintawee; Dimple Butani; Yi Wang; Yaroslava Zemlyanska; Chong Boon Nigel Wong; Suchin Virabhak; M A Hrishikesh; Yot Teerawattananon
Journal:  BMJ Open       Date:  2022-04-05       Impact factor: 2.692

5.  The Future of Precision Medicine: Potential Impacts for Health Technology Assessment.

Authors:  James Love-Koh; Alison Peel; Juan Carlos Rejon-Parrilla; Kate Ennis; Rosemary Lovett; Andrea Manca; Anastasia Chalkidou; Hannah Wood; Matthew Taylor
Journal:  Pharmacoeconomics       Date:  2018-12       Impact factor: 4.981

6.  A Systematic Review of the Value Assessment Frameworks Used within Health Technology Assessment of Omics Technologies and Their Actual Adoption from HTA Agencies.

Authors:  Ilda Hoxhaj; Laurenz Govaerts; Steven Simoens; Walter Van Dyck; Isabelle Huys; Iñaki Gutiérrez-Ibarluzea; Stefania Boccia
Journal:  Int J Environ Res Public Health       Date:  2020-10-30       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.